20225 ⎘
Medicinal preparations containing organic active ingredients; Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO)
Aerosolized Dapsone as a Therapy for Inflammation of the Airway and Abnormal Mucociliary Transport
#602Enhanced glycemic control using Ad36E4orf1 and AKT1 inhibitor
#603Pharmaceutical composition for preventing or treating muscle wasting-related disease comprising diaminodiphenylsulfone or pharmaceutically acceptable salt thereof
#604FORMULATIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF PRE-MCI AND/OR PRE-ALZHEIMER'S CONDITIONS
#605Hydroxytyrosol combinations for enhancing mitochondrial function and energy production
#606Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#607Inhibition of the glycine cleavage system for treatment of cancer
#608Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase I in the treatment of disorders
#609Inhibition of Filovirus Entry Into Cells and Uses Thereof
#610Delayed release cysteamine bead formulation, and methods of making and using same
#611Antimicrobial compositions with cysteamine
#612METHODS OF TREATMENT USING ARYLCYCLOPROPYLAMINE COMPOUNDS
#613Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
#614Nutritional supplements
#615CYSTEAMINE AND/OR CYSTAMINE FOR TREATING ISCHEMIC INJURY
#616Use of Cysteamine and Derivatives Thereof to Suppress Tumor Metastases
#617Aldehyde dehydrogenase inhibitors as novel depigmenting agents
#618Pharmaceutical Composition for Preventing or Treating Disease with Bone Mass Loss Comprising Diaminodiphenylsulfone or Pharmaceutically Acceptable Salt Thereof
#619KCNQ channels as therapeutic targets
#620USE OF CYSTEAMINE IN TREATING PARKINSON'S DISEASE
#621Dietary product intended for the prevention of cardiometabolic risk
#622Cysteamine in the treatment of fibrotic disease
#623Hot melt granulation formulations of poorly water-soluble active agents
#624Organic Compounds
#625AMINO ALCOHOL DERIVATIVES FOR THE TREATMENT OF DEMYELINATING PERIPHERAL NEUROPATHIES
#626Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome
#627Diagnosis, prognosis, and treatment of kidney disease
#628Method and composition for treating an alpha adrenoceptor-mediated condition
#629Use of Th9 cells and IL-9 for the treatment of melanoma
#630TREATMENT AND PREVENTION OF DISEASES MEDIATED BY MICROORGANISMS VIA DRUG-MEDIATED MANIPULATION OF THE EICOSANOID BALANCE
#631Methods of reducing levels of tau
#632LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISEASES OR DISORDERS
#633Methods of treating giardiasis
#634Topical dapsone and dapsone/adaplene compositions and methods for use thereof
#635Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
#636Selecting use of proteasome inhibitors based on NF-κB2 sequence
#637NITRITE COMPOSITIONS AND USES THEREOF
#638Treatment of cerebral ischemia
#639CYSTAMINE ANALOGUES FOR THE TREATMENT OF PARKINSON'S DISEASE
#640Treatment for vitiligo
#641Dapsone to treat rosacea
#642DISULFIRAM FORMULATION AND USES THEREOF
#643METHOD AND KIT FOR ADMIINISTERING GAMMA-GLUTAMYL-D-CYSTEINE FOR THE PREVENTION OF REPERFUSION INJURY FOLLOWING ISCHEMIC STROKE
#644Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers
#645Compounds as L-cystine crystallization inhibitors and uses thereof
#646Materials and methods for treating viral infections
#647Methods for Improved Delivery of Aminothiols, Dimers of Aminothiols, and Heterodimers Composed of Aminothiols
#648TREATMENT OF MECP-2 ASSOCIATED DISORDERS
#649Combined therapy for cystic fibrosis
#650Method of improving absorption of vitamin E by a pet animal
#651Pharmaceutical Kit for Treating Neuronal Damages
#6526,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS
#653Methods and compositions for protection of cells and tissues from computed tomography radiation
#654Pharmaceutical composition and method of treating a microbial infection with sulcotidil
#655ROS-activated compounds as selective anti-cancer therapeutics
#656Methods and compositions for treatment of cancer and autoimmune disease
#657Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
#658Compounds useful for treating and/or preventing disease-associated bone loss
#659Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis
#660Methods and compositions for treatment of autism
#661Compounds and their use
#662Aldehyde dehydrogenase inhibitors as novel depigmenting agents
#663Baclofen and acamprosate based therapy of neurological disorders
#664Epigenetic co-repressors of the gamma-globin gene and methods of using same
#665Herbal-Based Solution for Treating Symptoms of Nasal Conditions
#666AEROSOLIZED DAPSONE AS A THERAPY FOR INFLAMMATION OF THE AIRWAY AND ABNORMAL MUCOCILIARY TRANSPORT
#667PHARMACEUTICAL KIT FOR TREATING NEURONAL DAMAGES
#668Compositions and methods for treatment of chronic fatigue
#669Antibiotic compositions comprising an antibiotic agent and cysteamine
#670Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers
#671Use of Cysteamine in Treating Parkinson's Disease
#672Edible energy composition
#673METHODS FOR TREATING OR PREVENTING ALCOHOL-RELATED DISORDERS OR CRAVING-RELATED DISORDERS
#674METAL DELIVERY AGENTS AND THERAPEUTIC USES OF THE SAME
#675SUBSTITUTED HALOPHENOXYBENZAMIDE DERIVATIVES
#676USE OF S1P RECEPTOR MODULATOR
#677MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE
#678ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
#679HYDROXYTYROSOL COMBINATIONS FOR ENHANCING MITOCHONDRIAL FUNCTION AND ENERGY PRODUCTION
#680Methods for the biosynthesis of taurine or hypotaurine in cells
#681Inhibition of biofilm organisms
#682Method for treating phytophotodermatitis
#683Degradable networks for sustained release and controlled release depot drug delivery applications
#684Soluble pharmaceutical formulations of N,N′-diaminodiphenyl sulfone for optimal use in the treatment of various diseases
#685High penetration prodrug compositions of peptides and peptide-related compounds
#686Edible energy composition
#687Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#688Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
#689Methods of treating mild cognitive impairment (MCI) and related disorders
#690Anti-aging agents and methods to identify them
#691Enterically coated cysteamine, cystamine and derivatives thereof
#692Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
#693Targeting PAX2 for the treatment of breast cancer
#694Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde
#695Methods of using diacerein as an adjunctive therapy for diabetes
#696TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#697Inhibitors
#698Method of treating inflammation with statins
#699TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#700TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#701Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders
#702Targeting PAX2 for the treatment of breast cancer
#703Targeting PAX2 for the treatment of breast cancer
#704Targeting PAX2 for the treatment of breast cancer
#705TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#706TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#707TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#708USE OF IMMUNOSUPPRESSANT COMPOUNDS IN A NEW INDICATION
#709Polysaccharide Based Antimicrobial Formulations
#710Compounds as L-cystine crystallization inhibitors and uses thereof
#711METHODS OF USE RELATED TO XEROSTOMIA
#712Nutritional composition for improving muscle function and daily activity
#713ORGANIC COMPOUNDS
#714ANTIMICROBIAL N-HALOGENATED AMINO ACID SALTS
#715Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents
#716Inhibition of the Survival of Colorectal Cancer by Cyclohexenone Compounds from Antrodia Camphorata
#717ANTIBACTERIAL COMBINATION THERAPY
#718Nutritional supplements
#719PHARMACEUTICAL COMPOSITIONS CONTAINING AN INCLUSION COMPLEX FORMED BY DISULFIRAM AND A CYCLODEXTRINE, WHICH CAN BE USED IN THE TREATMENT OF ALCOHOL AND COCAINE DEPENDENCE
#720Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers
#721COMPOSITIONS AND METHODS OF TREATING NEOPLASIA
#722USE OF ANGIOGENESIS ANTAGONISTS IN CONDITIONS OF ABNORMAL VENOUS PROLIFERATION
#723DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#724Pharmaceutical delivery systems for treatment of substance abuse and other addictions
#725COMPOSITION AND METHOD FOR TREATING ACNE
#726Dapsone to treat rosascea
#727Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
#728Method and composition for treating an alpha adrenoceptor-mediated condition
#729Anti aging agents and methods to identify them
#730C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for the Treatment of Anxiety Disorders
#731Aldehyde dehydrogenase inhibitors as novel depigmenting agents
#732Nuclease compositions and methods
#733Targeting PAX2 for the treatment of breast cancer
#734Antibacterial S-heterosubstituted disulfides
#735IMPLANTS CONTAINING DISULFIRAM AND AN ANTI-INFLAMMATORY AGENT
#736Anticonvulsive pharmaceutical compositions
#737Ischemic disorder or disease inhibitors
#738Delivery devices for modulating inflammation
#739Delivery devices for modulating inflammation
#740Delivery devices for modulating inflammation
#741USE OF SUBSTANCES THAT ACT AS CASCADE INHIBITORS OF THE RAF/MEK/ERK SIGNAL CASCADE, FOR PRODUCING A MEDICAMENT TO TREAT DNA AND RNA VIRUSES
#742Anti-inflammatory compositions and methods
#743Anti-inflammatory compositions and methods
#744Systems for modulating inflammation
#745Systems for modulating inflammation
#746Systems for modulating inflammation
#747Systems for modulating inflammation
#748Anti-inflammatory compositions and methods
#749Anti-inflammatory compositions and methods
#750Delivery devices for modulating inflammation
#751ACETAMIDOPROPANE MODULATORS OF NMDA RECEPTORS
#752Antiviral supplement formulations
#753Effective use method of medicaments and method of preventing expression of side effect
#754USE OF S1P RECEPTOR MODULATOR
#755Inhibition of mitogen-activated protein kinases in cardiovascular disease
#756ENDOTHELIN RECEPTOR ANTAGONISTS FOR EARLY STAGE IDIOPATHIC PULMONARY FIBROSIS
#757-(2-phenyl-cyclohexyl)-methylamine compounds for therapy of fibromyalgia
#758Edible energy composition
#759High penetration prodrug compositions of peptides and peptide-related compounds
#760Therapeutic Use of Methionine to Reduce the Toxicity of Aminoglycoside Antibiotics
#761ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS
#762Materials and Methods for Improving the health of Shrimp
#763Solid Pharmaceutical Compositions Comprising a SIP Receptor Agonist and a Sugar Alcohol
#764ANTIMICROBIAL N-HALOGENATED AMINO ACID SALTS
#765INHIBITORS OF NITRIC OXIDE SYNTHASE
#766Pharmaceutical Compositions and Methods Utilizing a D-Amino Acid
#767Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
#768Method and apparatus for introducing a medicinal dose directly into a mammalian patient's cerebrospinal fluid
#769Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde
#770Drugs With Improved Hydrophobicity For Incorporation in Medical Devices
#771Enterically coated cystamine, cysteamine and derivatives thereof
#772CHEMICAL COMPOUNDS
#773Inhibitors of melanocyte tyrosinase as topical skin lighteners
#774Inhibitors of melanocyte tyrosinase as topical skin lighteners
#775PREVENTION OF HYPOTENSION AND STABILIZATION OF BLOOD PRESSURE IN HEMODIALYSIS PATIENTS
#776COMPOSITION AND METHOD FOR TREATING ALCOHOLISM AND OTHER SUBSTANCE ADDICTIONS
#777Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol
#778METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS
#779Methods for modulating neuronal cell death
#780SYSTEM FOR TREATING ADDICTIONS
#781Methods for Treating Stress and Affecting Biological Immune Systems
#782Treatment of Asthma with Aryl Sulfonamides
#783METHODS FOR THE TREATMENT OF ALCOHOL ABUSE, ADDICTION AND DEPENDENCY
#784Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#785Thiol reactive agents as a therapeutic modality
#786METHOD OF USING AJOENE AS ALCOHOL DEHYDROGENASE INHIBITOR, COMPOSITION FOR REMOVING HANGOVER COMPRISING AJOENE AND METHOD OF PREPARING THE SAME
#787Antiretroviral combination therapy
#788Interleukin-9 mutein peptides
#789Effective use method of medicaments and method of preventing expression of side effect
#790Method for inhibiting or reversing non-enzymatic glycation
#791USE OF CARP INHIBITORS FOR THE TREATMENT OF HEART DISEASES
#792Combination therapy for anthrax using antibiotics and protease inhibitors
#793Liquid Concentrated Formula
#794Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
#795Materials and methods for treating viral infections
#796Therapeutic Agents
#797Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events
#798Method of using ajoene as alcohol dehydrogenase inhibitor, composition for removing hangover comprising ajoene and method of preparing the same
#799Inhibitors of nitric oxide synthase to treat type 1 diabetes
#800Organic compounds
#801Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds
#802C-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders
#803Controlled release venlafaxine formulations
#804Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies
#805Controlled release O-desmethylvenlafaxine formulations
#806Controlled release venlafaxine formulations
#807Therapeutic use of methionine-derivitives to reduce the toxicity of noise
#808Method and dietary composition for improving lipid digestibility
#809Nutritional compositions and use thereof
#810Particulate product comprising pantethine
#811Inhibition of mitogen-activated protein kinases in cardiovascular disease
#812Methods of use related to xerostomia
#813Uses of acylated aminopropanediols and sulphur and nitrogen analogues of same f
#814Drug or cosmetic
#815ABCA-1 elevating compounds
#816Method of improving absorption of vitamin E by a pet animal
#817Application of substances acting as cascade inhibitors of the Raf/MEK/ERK signaling cascade for the production of a drug against DNA and RNA viruses
#818Therapeutic agents
#819Inhibitors of melanocyte tyrosinase as topical skin lighteners
#820Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers
#821Method and dietary composition for improving fat digestibility
#822Transplant rejection suppressor
#823Composition with multiple uses for poultry
#824Method for treatment of glutamate related disorders
#825Phenylalanine-based LAT1 inhibitors and uses thereof
#826Systems and methods for preparing and administering a hydrating supplement composition
#827Compositions and methods for minimizing effects of alcohol intoxication
#828Antitoxins to brevetoxin
#829Pharmaceutical compositions and methods of administration
#830Method and system for the treatment of medical conditions by intravenous therapy
#831Selective inhibitors of EG5 motors and methods of use
#832Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems